The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Bioerodible polyanhydrides as drug‐carrier matrices. II. Biocompatibility and chemical reactivity
Abstract
The biocompatibility of bioerodible polyanhydrides and toxicology of the polymer breakdown products were assessed. Poly‐[bis (p‐carboxy‐phenoxy) propane anhydride] (PCPP), Poly(terephthalic acid anhydride) (PTA), and their copolymers with sebacic acid were tested. The polymers did not provoke inflammatory responses in the corneas of rabbits over a six week implantation period. Subcutaneous implantation studies of PCPP in rats over a six month period showed no evidence of inflammatory cells and only slight tissue encapsulation by layers of fibroblastic cells. The degradation products of the polymers were nonmutagenic, noncytotoxic, and had a low teratogenic potential. The in vitro growth of mammalian cells on the polymers was unaffected as measured by cell morphology and cell growth rate. The chemical reactivity of the polyanhydrides with reactive model drugs, para substituted anilines, was also examined. Amides were formed when the drugs were injection molded with the polyanhydrides at 120°C. However, no reaction was observed using compression molding at room temperature. No reaction occurred between the polymer and the drug during the hydrolytic degradation of the matrix at 37°C.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jaffe, E. A., Nachman, R. L., Becker, C. G., & Minick, C. R. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107470 · Cited by 6,856
Ross, R. (1971) · The Journal of Cell Biology · doi:10.1083/jcb.50.1.172 · Cited by 1,569
Synthesis of Antihemophilic Factor Antigen by Cultured Human Endothelial Cells
Jaffe, E. A., Hoyer, L. W., & Nachman, R. L. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107471 · Cited by 1,273
Leong, K. W., Brott, B. C., & Langer, R. (1985) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820190806 · Cited by 541
Self-citationSarcomas Induced in Rats by Implanting Cellophane
Oppenheimer, B. S., Oppenheimer, E. T., & Stout, A. P. (1948) · Experimental Biology and Medicine · doi:10.3181/00379727-67-16195p · Cited by 165
Skopek, T. R., Liber, H. L., Krolewski, J. J., & Thilly, W. G. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.1.410 · Cited by 153
Controlled Release of Polypeptides and Other Macromolecules
Siegel, R. A., & Langer, R. (1984) · Pharmaceutical Research · doi:10.1023/a:1016318423563 · Cited by 133
Self-citationBiocompatibility of polymeric delivery systems for macromolecules
Langer, R., Brem, H., & Tapper, D. (1981) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820150212 · Cited by 131
Self-citationMicrosomal Dealkylation of Drugs
McMahon, R. E. (1966) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600550502 · Cited by 129
Toxicological Evaluation of Biomaterials: Primary Acute Toxicity Screening Program
Autian, J. (1977) · Artificial Organs · doi:10.1111/j.1525-1594.1977.tb00968.x · Cited by 115
Cited by
Polymeric systems for controlled drug release
Uhrich, K. E., Cannizzaro, S. M., Langer, R. S., & Shakesheff, K. M. (1999) · Chemical Reviews · doi:10.1021/cr940351u · Cited by 2,633
Self-citationLanger, R. (1990) · Science · doi:10.1126/science.2218494 · Cited by 1,778
Self-citationNew Challenges in Biomaterials
Peppas, N. A., & Langer, R. (1994) · Science · doi:10.1126/science.8134835 · Cited by 1,142
Self-citationAdvances in biomaterials, drug delivery, and bionanotechnology
Langer, R., & Peppas, N. A. (2003) · AIChE Journal · doi:10.1002/aic.690491202 · Cited by 966
Self-citationEngelberg, I., & Kohn, J. (1991) · Biomaterials · doi:10.1016/0142-9612(91)90037-b · Cited by 803
Biomaterials in Drug Delivery and Tissue Engineering: One Laboratory's Experience
Langer, R. (2000) · Accounts of Chemical Research · doi:10.1021/ar9800993 · Cited by 750
Self-citationRecent Perspectives in Ocular Drug Delivery
Gaudana, R., Jwala, J., Boddu, S. H. S., & Mitra, A. K. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9694-0 · Cited by 605
Selective cell transplantation using bioabsorbable artificial polymers as matrices
Vacanti, J. P., Morse, M. A., Saltzman, W. M., Domb, A. J., Perez-Atayde, A., & Langer, R. (1988) · Journal of Pediatric Surgery · doi:10.1016/s0022-3468(88)80529-3 · Cited by 602
Self-citationLeong, K. W., Brott, B. C., & Langer, R. (1985) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820190806 · Cited by 541
Self-citationInterstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas
Brem, H., Mahaley, M. S., Vick, N. A., Black, K. L., Schold, S. C., Burger, P. C., Friedman, A. H., Ciric, I. S., Eller, T. W., Cozzens, J. W., et al. (1991) · Journal of Neurosurgery · doi:10.3171/jns.1991.74.3.0441 · Cited by 488
Hefti, F., Hartikka, J., & Knusel, B. (1989) · Neurobiology of Aging · doi:10.1016/0197-4580(89)90118-8 · Cited by 466
Getting into the Brain: Approaches to Enhance Brain Drug Delivery
Patel, M. M., Goyal, B. R., Bhadada, S. V., Bhatt, J. S., & Amin, A. F. (2009) · CNS Drugs · doi:10.2165/0023210-200923010-00003 · Cited by 461
Improving protein therapeutics with sustained-release formulations
Putney, S. D., & Burke, P. A. (1998) · Nature Biotechnology · doi:10.1038/nbt0298-153 · Cited by 460
Biodegradable Polymers for Protein and Peptide Drug Delivery
Gombotz, W. R., & Pettit, D. K. (1995) · Bioconjugate Chemistry · doi:10.1021/bc00034a002 · Cited by 448
Degradable Polymer Microspheres for Controlled Drug Delivery
Edlund, U., & Albertsson, A. C. (2002) · Advances in Polymer Science · doi:10.1007/3-540-45734-8_3 · Cited by 416
Kumar, N., Langer, R. S., & Domb, A. J. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00050-9 · Cited by 394
Self-citationErosion kinetics of hydrolytically degradable polymers.
Tamada, J. A., & Langer, R. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.552 · Cited by 356
Self-citationBiodegradable Polymers for Microencapsulation of Drugs
Park, J., Ye, M., & Park, K. (2005) · Molecules · doi:10.3390/10010146 · Cited by 317
Toxicity, biodegradation and elimination of polyanhydrides
Katti, D. S., Lakshmi, S., Langer, R., & Laurencin, C. T. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00052-2 · Cited by 305
Self-citationVaccine adjuvants: Current challenges and future approaches
Wilson-Welder, J. H., Torres, M. P., Kipper, M. J., Mallapragada, S. K., Wannemuehler, M. J., & Narasimhan, B. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21523 · Cited by 296
Pharmacokinetics of the Carmustine Implant
Fleming, A. B., & Saltzman, W. M. (2002) · Clinical Pharmacokinetics · doi:10.2165/00003088-200241060-00002 · Cited by 287
A review of photocrosslinked polyanhydrides:
Burkoth, A. K., & Anseth, K. S. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00107-1 · Cited by 191
Synthesis of degradable, biocompatible, and tough block‐copolyesterurethanes
Hirt, T. D., Neuenschwander, P., & Suter, U. W. (1996) · Macromolecular Chemistry and Physics · doi:10.1002/macp.1996.021971221 · Cited by 78
Metadata
- Authors
- Leong, K. W., D'Amore, P., Marletta, M., & Langer, R.
- Venue
- Journal of Biomedical Materials Research
- Publisher
- Wiley
- Published
- 1986-01
- Volume
- 20
- Issue
- 1
- Pages
- 51-64
- ISSN
- 0021-9304 (ISSN-L)
- 1097-4636
- OpenAlex
- W1999625274
- Cited by
- 261
- References
- 15
- FWCI
- 8.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.